Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -10,00k | 886,59k | Derivative Exercise and Sale | 81,49 - 170,81 | 54,73k | - |
| 2026-06-05 | Dr. Stephen A. SherwinIndependent Director | -25,00k | 2,53M | Derivative Exercise and Sale | 53,64 - 167,31 | 15,86k | - |
| 2026-06-05 | Dr. Jude OnyiaChief Scientific Officer | -2,44k | 0,00 | Other Disposition | - | 23,41k | -9,44% |
| 2026-06-04 | Ms. Leslie V. NorwalkIndependent Director | -1,25k | 210,07k | Automatic Disposition | 168,06 | 2,84k | -30,58% |
| 2026-06-02 | Ms. Julie S. CookeChief HR Officer | -11,97k | 1,89M | Automatic Disposition | 157,62 - 158,59 | 22,37k | -34,86% |
| 2026-06-02 | Ms. Julie S. CookeChief HR Officer | -24,97k | 1,85M | Derivative Exercise and Sale | 81,49 - 157,62 | 22,37k | - |
| 2026-06-02 | Dr. Sanjay KeswaniChief Medical Officer | 1,48k | 0,00 | Derivative Exercise and Retained Stock | - | 1,48k | - |
| 2026-06-02 | Dr. Sanjay KeswaniChief Medical Officer | -1,73k | 268,34k | Derivative Exercise and Sale | 154,84 | 1,48k | - |
| 2026-06-01 | Dr. Jude OnyiaChief Scientific Officer | -11,00k | 830,57k | Derivative Exercise and Sale | 84,74 - 160,25 | 25,85k | - |
| 2026-05-29 | Dr. Ingrid DelaetChief Regulatory Officer | -2,26k | 175,66k | Derivative Exercise and Sale | 79,02 - 156,71 | 16,23k | - |
| 2026-05-27 | Dr. Jude OnyiaChief Scientific Officer | -11,00k | 778,73k | Derivative Exercise and Sale | 84,74 - 155,53 | 25,85k | - |
| 2026-05-26 | Mr. David Warren BoyerChief Corporate Affairs Officer | -3,89k | 609,02k | Automatic Disposition | 156,64 | 7,80k | -33,27% |
| 2026-05-21 | Dr. Stephen A. SherwinIndependent Director | 3,32k | 0,00 | Derivative Exercise and Retained Stock | - | 15,86k | 26,46% |
| 2026-05-21 | Dr. William H. RastetterIndependent Chairman of the Board | 3,32k | 0,00 | Derivative Exercise and Retained Stock | - | 43,68k | 8,22% |
| 2026-05-21 | Ms. Shalini SharpIndependent Director | 1,66k | 0,00 | Derivative Exercise and Retained Stock | - | 4,09k | 68,30% |
| 2026-05-21 | Mr. Richard F. PopsIndependent Director | 3,32k | 0,00 | Derivative Exercise and Retained Stock | - | 37,80k | 9,62% |
| 2026-05-21 | Ms. Christine Ann PoonIndependent Director | 3,32k | 0,00 | Derivative Exercise and Retained Stock | - | 4,75k | 231,22% |
| 2026-05-21 | Mr. George J. MorrowIndependent Director | 3,32k | 0,00 | Derivative Exercise and Retained Stock | - | 10,39k | 46,94% |
| 2026-05-21 | Ms. Leslie V. NorwalkIndependent Director | 1,66k | 0,00 | Derivative Exercise and Retained Stock | - | 4,09k | 68,30% |
| 2026-05-21 | Mr. Gary A. LyonsIndependent Director | 1,66k | 0,00 | Derivative Exercise and Retained Stock | - | 122,14k | 1,38% |
| 2026-05-21 | Ms. Johanna MercierIndependent Director | 3,32k | 0,00 | Derivative Exercise and Retained Stock | - | 6,85k | 93,86% |
| 2026-05-19 | Dr. Kevin C. GormanDirector | -205,09k | 22,78M | Derivative Exercise and Sale | 43,24 - 154,33 | 511,29k | - |
| 2026-05-19 | Dr. Kevin C. GormanDirector | -40,00k | 6,17M | Automatic Disposition | 154,33 | 511,29k | -7,26% |
| 2026-05-15 | Mr. Richard F. PopsIndependent Director | -15,00k | 1,65M | Derivative Exercise and Sale | 47,89 - 157,65 | 34,48k | - |
| 2026-05-12 | Ms. Leslie V. NorwalkIndependent Director | -3,81k | 590,60k | Automatic Disposition | 155,01 | 2,43k | -61,07% |
| 2026-03-04 | Mr. Matthew C. AbernethyCFO | -2,25k | 0,00 | Other Disposition | - | 42,81k | -4,99% |
| 2026-02-20 | Dr. Jude OnyiaChief Scientific Officer | -3,11k | 0,00 | Other Disposition | - | 25,67k | -10,81% |
| 2026-02-12 | Mr. David Warren BoyerChief Corporate Affairs Officer | 2,28k | 0,00 | Derivative Exercise and Retained Stock | - | 11,58k | 24,49% |
| 2026-02-12 | Mr. David Warren BoyerChief Corporate Affairs Officer | -2,67k | 331,02k | Derivative Exercise and Sale | 123,10 - 124,12 | 11,58k | - |
| 2026-02-13 | Mr. David Warren BoyerChief Corporate Affairs Officer | -5,38k | 667,52k | Sale to Issuer | 124,12 | 11,58k | -31,71% |
| 2026-02-12 | Mr. Matthew C. AbernethyCFO | 3,19k | 0,00 | Derivative Exercise and Retained Stock | - | 44,88k | 7,66% |
| 2026-02-12 | Mr. Matthew C. AbernethyCFO | -3,75k | 463,78k | Derivative Exercise and Sale | 123,10 - 124,12 | 44,88k | - |
| 2026-02-13 | Mr. Matthew C. AbernethyCFO | -5,38k | 667,52k | Sale to Issuer | 124,12 | 44,88k | -10,70% |
| 2026-02-12 | Mr. Kyle W. GanoPresident, CEO & Director | 4,47k | 0,00 | Derivative Exercise and Retained Stock | - | 150,82k | 3,06% |
| 2026-02-12 | Mr. Kyle W. GanoPresident, CEO & Director | -5,24k | 648,06k | Derivative Exercise and Sale | 123,10 - 124,12 | 150,82k | - |
| 2026-02-13 | Mr. Kyle W. GanoPresident, CEO & Director | -5,38k | 667,52k | Sale to Issuer | 124,12 | 150,82k | -3,44% |
| 2026-02-12 | Mr. Eric S. BenevichChief Commercial Officer | 2,79k | 0,00 | Derivative Exercise and Retained Stock | - | 63,19k | 4,61% |
| 2026-02-12 | Mr. Eric S. BenevichChief Commercial Officer | -3,26k | 404,02k | Derivative Exercise and Sale | 123,10 - 124,12 | 63,19k | - |
| 2026-02-13 | Mr. Eric S. BenevichChief Commercial Officer | -8,96k | 1,11M | Sale to Issuer | 124,12 | 63,19k | -12,42% |
| 2026-02-12 | Dr. Jude OnyiaChief Scientific Officer | 3,62k | 0,00 | Derivative Exercise and Retained Stock | - | 28,78k | 14,40% |
| 2026-02-12 | Dr. Jude OnyiaChief Scientific Officer | -4,34k | 537,72k | Derivative Exercise and Sale | 123,10 - 124,12 | 28,78k | - |
| 2026-02-13 | Dr. Jude OnyiaChief Scientific Officer | -10,76k | 1,33M | Sale to Issuer | 124,12 | 28,78k | -27,20% |
| 2026-02-12 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | 2,71k | 0,00 | Derivative Exercise and Retained Stock | - | 54,73k | 5,21% |
| 2026-02-12 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -3,18k | 393,72k | Derivative Exercise and Sale | 123,10 - 124,12 | 54,73k | - |
| 2026-02-13 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -5,38k | 667,52k | Sale to Issuer | 124,12 | 54,73k | -8,95% |
| 2026-02-13 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -365,00 | 0,00 | Other Disposition | - | 54,73k | -0,66% |
| 2026-02-12 | Ms. Julie S. CookeChief HR Officer | 1,98k | 0,00 | Derivative Exercise and Retained Stock | - | 34,17k | 6,14% |
| 2026-02-12 | Ms. Julie S. CookeChief HR Officer | -2,32k | 287,19k | Derivative Exercise and Sale | 123,10 - 124,12 | 34,17k | - |
| 2026-02-13 | Ms. Julie S. CookeChief HR Officer | -5,38k | 667,52k | Sale to Issuer | 124,12 | 34,17k | -13,60% |
| 2026-02-13 | Dr. Kevin C. GormanDirector | 5,06k | 0,00 | Derivative Exercise and Retained Stock | - | 551,29k | 0,93% |
| 2026-02-13 | Dr. Kevin C. GormanDirector | -5,93k | 735,41k | Derivative Exercise and Sale | 124,12 | 551,29k | - |
| 2026-02-13 | Dr. Kevin C. GormanDirector | -34,38k | 4,27M | Sale to Issuer | 124,12 | 551,29k | -5,87% |
| 2026-02-12 | Dr. Ingrid DelaetChief Regulatory Officer | 1,99k | 0,00 | Derivative Exercise and Retained Stock | - | 16,23k | 13,97% |
| 2026-02-12 | Dr. Ingrid DelaetChief Regulatory Officer | -2,37k | 293,39k | Derivative Exercise and Sale | 123,10 - 124,12 | 16,23k | - |
| 2026-02-13 | Dr. Ingrid DelaetChief Regulatory Officer | -10,76k | 1,33M | Sale to Issuer | 124,12 | 16,23k | -39,86% |
| 2026-01-31 | Mr. David Warren BoyerChief Corporate Affairs Officer | 907,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,71k | 23,83% |
| 2026-01-31 | Mr. David Warren BoyerChief Corporate Affairs Officer | -1,19k | 161,78k | Derivative Exercise and Sale | 136,06 | 4,71k | - |
| 2026-01-31 | Mr. Eric S. BenevichChief Commercial Officer | 1,00k | 0,00 | Derivative Exercise and Retained Stock | - | 52,76k | 1,94% |
| 2026-01-31 | Mr. Eric S. BenevichChief Commercial Officer | -1,29k | 175,79k | Derivative Exercise and Sale | 136,06 | 52,76k | - |
| 2026-01-31 | Mr. Matthew C. AbernethyCFO | 1,07k | 0,00 | Derivative Exercise and Retained Stock | - | 37,10k | 2,97% |
| 2026-01-31 | Mr. Matthew C. AbernethyCFO | -1,37k | 186,13k | Derivative Exercise and Sale | 136,06 | 37,10k | - |
| 2026-01-31 | Ms. Julie S. CookeChief HR Officer | 744,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,60k | 2,77% |
| 2026-01-31 | Ms. Julie S. CookeChief HR Officer | -997,00 | 135,65k | Derivative Exercise and Sale | 136,06 | 27,60k | - |
| 2026-01-31 | Dr. Ingrid DelaetChief Regulatory Officer | 326,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,06k | 6,89% |
| 2026-01-31 | Dr. Ingrid DelaetChief Regulatory Officer | -475,00 | 64,63k | Derivative Exercise and Sale | 136,06 | 5,06k | - |
| 2026-01-31 | Mr. Kyle W. GanoPresident, CEO & Director | 1,35k | 0,00 | Derivative Exercise and Retained Stock | - | 141,75k | 0,96% |
| 2026-01-31 | Mr. Kyle W. GanoPresident, CEO & Director | -1,58k | 214,97k | Derivative Exercise and Sale | 136,06 | 141,75k | - |
| 2026-01-31 | Dr. Kevin C. GormanDirector | 2,30k | 0,00 | Derivative Exercise and Retained Stock | - | 516,89k | 0,45% |
| 2026-01-31 | Dr. Kevin C. GormanDirector | -2,85k | 387,09k | Derivative Exercise and Sale | 136,06 | 516,89k | - |
| 2026-01-31 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | 1,04k | 0,00 | Derivative Exercise and Retained Stock | - | 47,79k | 2,22% |
| 2026-01-31 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -1,34k | 181,64k | Derivative Exercise and Sale | 136,06 | 47,79k | - |
| 2026-01-31 | Dr. Jude OnyiaChief Scientific Officer | 96,00 | 0,00 | Derivative Exercise and Retained Stock | - | 15,98k | 0,60% |
| 2026-01-31 | Dr. Jude OnyiaChief Scientific Officer | -142,00 | 19,32k | Derivative Exercise and Sale | 136,06 | 15,98k | - |
| 2026-01-16 | Mr. Kyle W. GanoPresident, CEO & Director | -36,40k | 3,52M | Derivative Exercise and Sale | 35,99 - 132,71 | 140,41k | - |
| 2025-11-28 | Mr. Eric S. BenevichChief Commercial Officer | 12,83k | 461,75k | Derivative Exercise and Retained Stock | 35,99 | 51,75k | 32,96% |
| 2026-01-08 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | 3,35k | 120,53k | Derivative Exercise and Retained Stock | 35,99 | 46,75k | 7,72% |
| 2025-12-15 | Ms. Leslie V. NorwalkIndependent Director | 3,81k | 351,85k | Derivative Exercise and Retained Stock | 92,35 | 6,24k | 156,85% |
| 2025-12-15 | Ms. Leslie V. NorwalkIndependent Director | -6,19k | 386,81k | Derivative Exercise and Sale | 84,95 - 155,09 | 6,24k | - |
| 2025-12-08 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -4,38k | 509,40k | Derivative Exercise and Sale | 43,24 - 159,65 | 43,41k | - |
| 2025-12-03 | Mr. Gary A. LyonsIndependent Director | -15,00k | 1,57M | Derivative Exercise and Sale | 47,89 - 152,61 | 120,48k | - |
| 2025-11-29 | Dr. Jude OnyiaChief Scientific Officer | 2,18k | 0,00 | Derivative Exercise and Retained Stock | - | 15,88k | 15,89% |
| 2025-11-29 | Dr. Jude OnyiaChief Scientific Officer | -2,25k | 342,06k | Derivative Exercise and Sale | 152,16 | 15,88k | - |
| 2025-11-25 | Mr. George J. MorrowIndependent Director | -15,00k | 1,43M | Derivative Exercise and Sale | 47,89 - 143,37 | 7,07k | - |
| 2025-11-05 | Dr. William H. RastetterIndependent Chairman of the Board | -18,00k | 1,87M | Derivative Exercise and Sale | 47,89 - 151,82 | 40,36k | - |
| 2025-11-01 | Mr. Kyle W. GanoPresident, CEO & Director | 313,00 | 0,00 | Derivative Exercise and Retained Stock | - | 140,41k | 0,22% |
| 2025-11-01 | Mr. Kyle W. GanoPresident, CEO & Director | -300,00 | 42,59k | Derivative Exercise and Sale | 141,97 | 140,41k | - |
| 2025-09-03 | Dr. Jude OnyiaChief Scientific Officer | -1,47k | 0,00 | Other Disposition | - | 13,70k | -9,69% |
| 2025-09-02 | Dr. Stephen A. SherwinIndependent Director | -1.000,00 | 0,00 | Other Disposition | - | 12,54k | -7,38% |
| 2025-08-07 | Dr. Kevin C. GormanDirector | -106,32k | 9,61M | Derivative Exercise and Sale | 35,99 - 126,41 | 514,60k | - |
| 2025-08-05 | Dr. Jude OnyiaChief Scientific Officer | -3,12k | 0,00 | Other Disposition | - | 15,17k | -17,04% |
| 2025-07-10 | Dr. Ingrid DelaetChief Regulatory Officer | -457,00 | 25,58k | Derivative Exercise and Sale | 79,02 - 135,00 | 4,73k | - |
| 2025-07-09 | Dr. Jude OnyiaChief Scientific Officer | -59,82k | 2,73M | Derivative Exercise and Sale | 84,74 - 130,46 | 18,29k | - |
| 2025-07-02 | Dr. Jude OnyiaChief Scientific Officer | -20,36k | 924,26k | Derivative Exercise and Sale | 84,74 - 130,13 | 18,29k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
